nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C8—Sulfadiazine—malaria	0.0645	0.0942	CbGbCtD
Lapatinib—CYP2C8—Pyrimethamine—malaria	0.0645	0.0942	CbGbCtD
Lapatinib—CYP3A5—Artemether—malaria	0.0571	0.0833	CbGbCtD
Lapatinib—CYP2C19—Artemether—malaria	0.046	0.0672	CbGbCtD
Lapatinib—CYP3A4—Clindamycin—malaria	0.0456	0.0665	CbGbCtD
Lapatinib—CYP2C19—Proguanil—malaria	0.0433	0.0631	CbGbCtD
Lapatinib—CYP3A5—Quinine—malaria	0.0346	0.0504	CbGbCtD
Lapatinib—CYP2C8—Quinine—malaria	0.0332	0.0485	CbGbCtD
Lapatinib—CYP2C8—Quinidine—malaria	0.0292	0.0426	CbGbCtD
Lapatinib—CYP2C19—Quinine—malaria	0.0279	0.0407	CbGbCtD
Lapatinib—CYP3A5—Dapsone—malaria	0.0262	0.0382	CbGbCtD
Lapatinib—CYP3A4—Sulfadiazine—malaria	0.0262	0.0382	CbGbCtD
Lapatinib—CYP2C8—Dapsone—malaria	0.0252	0.0368	CbGbCtD
Lapatinib—ABCB1—Quinine—malaria	0.0225	0.0328	CbGbCtD
Lapatinib—CYP3A4—Artemether—malaria	0.0222	0.0325	CbGbCtD
Lapatinib—CYP2C19—Dapsone—malaria	0.0211	0.0308	CbGbCtD
Lapatinib—CYP3A4—Proguanil—malaria	0.0209	0.0305	CbGbCtD
Lapatinib—CYP3A4—Doxycycline—malaria	0.0198	0.0289	CbGbCtD
Lapatinib—ABCB1—Quinidine—malaria	0.0198	0.0289	CbGbCtD
Lapatinib—CYP3A4—Quinine—malaria	0.0135	0.0197	CbGbCtD
Lapatinib—CYP3A4—Quinidine—malaria	0.0118	0.0173	CbGbCtD
Lapatinib—CYP3A4—Dapsone—malaria	0.0102	0.0149	CbGbCtD
Lapatinib—Cardiotoxicity—Quinidine—malaria	0.00652	0.044	CcSEcCtD
Lapatinib—Cardiotoxicity—Quinine—malaria	0.00652	0.044	CcSEcCtD
Lapatinib—Cardiotoxicity—Quinidine barbiturate—malaria	0.00588	0.0397	CcSEcCtD
Lapatinib—TAP1—saliva-secreting gland—malaria	0.00523	0.0525	CbGeAlD
Lapatinib—PIK3C2B—saliva-secreting gland—malaria	0.00491	0.0493	CbGeAlD
Lapatinib—PIK3C2B—hematopoietic system—malaria	0.00468	0.047	CbGeAlD
Lapatinib—ERBB2—saliva-secreting gland—malaria	0.00382	0.0383	CbGeAlD
Lapatinib—ERBB4—saliva-secreting gland—malaria	0.00382	0.0383	CbGeAlD
Lapatinib—ERBB2—hematopoietic system—malaria	0.00364	0.0366	CbGeAlD
Lapatinib—PI4KB—saliva-secreting gland—malaria	0.00358	0.0359	CbGeAlD
Lapatinib—TAP1—blood—malaria	0.00331	0.0332	CbGeAlD
Lapatinib—TAP1—bone marrow—malaria	0.0032	0.0321	CbGeAlD
Lapatinib—PIK3C2B—blood—malaria	0.0031	0.0312	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—malaria	0.003	0.0302	CbGeAlD
Lapatinib—ERBB2—kidney—malaria	0.00299	0.03	CbGeAlD
Lapatinib—PI4KB—kidney—malaria	0.0028	0.0281	CbGeAlD
Lapatinib—TAP1—liver—malaria	0.00258	0.026	CbGeAlD
Lapatinib—ERBB2—digestive system—malaria	0.00253	0.0254	CbGeAlD
Lapatinib—Blood disorder—Sulfadiazine—malaria	0.00252	0.017	CcSEcCtD
Lapatinib—PIK3C2B—liver—malaria	0.00243	0.0244	CbGeAlD
Lapatinib—ERBB2—blood—malaria	0.00241	0.0242	CbGeAlD
Lapatinib—PI4KB—blood—malaria	0.00226	0.0227	CbGeAlD
Lapatinib—PI4KB—bone marrow—malaria	0.00219	0.022	CbGeAlD
Lapatinib—CYP2C19—blood plasma—malaria	0.00205	0.0206	CbGeAlD
Lapatinib—TAP1—brain—malaria	0.00205	0.0206	CbGeAlD
Lapatinib—Hepatotoxicity—Quinine—malaria	0.00199	0.0134	CcSEcCtD
Lapatinib—Hepatotoxicity—Quinidine—malaria	0.00199	0.0134	CcSEcCtD
Lapatinib—PIK3C2B—brain—malaria	0.00193	0.0193	CbGeAlD
Lapatinib—ERBB2—liver—malaria	0.00189	0.019	CbGeAlD
Lapatinib—Hepatotoxicity—Quinidine barbiturate—malaria	0.00179	0.0121	CcSEcCtD
Lapatinib—CYP2C8—blood plasma—malaria	0.00179	0.018	CbGeAlD
Lapatinib—PI4KB—liver—malaria	0.00177	0.0178	CbGeAlD
Lapatinib—Stomatitis—Proguanil—malaria	0.00173	0.0117	CcSEcCtD
Lapatinib—Hepatobiliary disease—Proguanil—malaria	0.00168	0.0113	CcSEcCtD
Lapatinib—CYP3A5—blood plasma—malaria	0.00162	0.0162	CbGeAlD
Lapatinib—EGFR—liver—malaria	0.0016	0.0161	CbGeAlD
Lapatinib—Leukopenia—Pyrimethamine—malaria	0.00159	0.0107	CcSEcCtD
Lapatinib—ERBB2—brain—malaria	0.0015	0.015	CbGeAlD
Lapatinib—ERBB4—brain—malaria	0.0015	0.015	CbGeAlD
Lapatinib—Anaphylactic shock—Pyrimethamine—malaria	0.00145	0.00979	CcSEcCtD
Lapatinib—Immune system disorder—Proguanil—malaria	0.00144	0.0097	CcSEcCtD
Lapatinib—Mediastinal disorder—Proguanil—malaria	0.00143	0.00968	CcSEcCtD
Lapatinib—PI4KB—brain—malaria	0.0014	0.0141	CbGeAlD
Lapatinib—Mental disorder—Proguanil—malaria	0.00139	0.00941	CcSEcCtD
Lapatinib—Malnutrition—Proguanil—malaria	0.00138	0.00935	CcSEcCtD
Lapatinib—Anorexia—Pyrimethamine—malaria	0.00138	0.00934	CcSEcCtD
Lapatinib—EGFR—brain—malaria	0.00127	0.0127	CbGeAlD
Lapatinib—Decreased appetite—Pyrimethamine—malaria	0.00126	0.00851	CcSEcCtD
Lapatinib—CYP3A4—blood plasma—malaria	0.00121	0.0122	CbGeAlD
Lapatinib—Cough—Proguanil—malaria	0.00121	0.00816	CcSEcCtD
Lapatinib—Renal failure acute—Quinine—malaria	0.00121	0.00815	CcSEcCtD
Lapatinib—Renal failure acute—Quinidine—malaria	0.00121	0.00815	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00117	0.00791	CcSEcCtD
Lapatinib—Neuropathy peripheral—Sulfadiazine—malaria	0.00115	0.00778	CcSEcCtD
Lapatinib—Stomatitis—Sulfadiazine—malaria	0.00115	0.00774	CcSEcCtD
Lapatinib—CYP2C19—hematopoietic system—malaria	0.00113	0.0114	CbGeAlD
Lapatinib—Nervous system disorder—Proguanil—malaria	0.00111	0.00748	CcSEcCtD
Lapatinib—Skin disorder—Proguanil—malaria	0.0011	0.00741	CcSEcCtD
Lapatinib—Renal failure acute—Quinidine barbiturate—malaria	0.00109	0.00736	CcSEcCtD
Lapatinib—Anorexia—Proguanil—malaria	0.00108	0.00727	CcSEcCtD
Lapatinib—Hypersensitivity—Pyrimethamine—malaria	0.00107	0.00722	CcSEcCtD
Lapatinib—Dry skin—Clindamycin—malaria	0.00104	0.00703	CcSEcCtD
Lapatinib—CYP2C8—hematopoietic system—malaria	0.00099	0.00994	CbGeAlD
Lapatinib—Decreased appetite—Proguanil—malaria	0.000982	0.00663	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Proguanil—malaria	0.000975	0.00659	CcSEcCtD
Lapatinib—Gastrointestinal pain—Proguanil—malaria	0.000924	0.00624	CcSEcCtD
Lapatinib—Vomiting—Pyrimethamine—malaria	0.000922	0.00623	CcSEcCtD
Lapatinib—Neutropenia—Clindamycin—malaria	0.000918	0.0062	CcSEcCtD
Lapatinib—Neutropenia—Quinidine—malaria	0.000901	0.00608	CcSEcCtD
Lapatinib—Neutropenia—Quinine—malaria	0.000901	0.00608	CcSEcCtD
Lapatinib—CYP3A5—hematopoietic system—malaria	0.000893	0.00897	CbGeAlD
Lapatinib—Abdominal pain—Proguanil—malaria	0.000893	0.00603	CcSEcCtD
Lapatinib—Neuropathy peripheral—Dapsone—malaria	0.000887	0.00599	CcSEcCtD
Lapatinib—ABCB1—blood plasma—malaria	0.000858	0.00862	CbGeAlD
Lapatinib—Epistaxis—Clindamycin—malaria	0.000826	0.00558	CcSEcCtD
Lapatinib—Leukopenia—Sulfadiazine—malaria	0.000823	0.00556	CcSEcCtD
Lapatinib—Neutropenia—Quinidine barbiturate—malaria	0.000813	0.00549	CcSEcCtD
Lapatinib—CYP2C8—kidney—malaria	0.000811	0.00815	CbGeAlD
Lapatinib—CYP2C19—digestive system—malaria	0.000789	0.00792	CbGeAlD
Lapatinib—Arthralgia—Sulfadiazine—malaria	0.000782	0.00528	CcSEcCtD
Lapatinib—Infestation—Pentoxifylline—malaria	0.000774	0.00523	CcSEcCtD
Lapatinib—Infestation NOS—Pentoxifylline—malaria	0.000774	0.00523	CcSEcCtD
Lapatinib—Diarrhoea—Proguanil—malaria	0.000773	0.00522	CcSEcCtD
Lapatinib—CYP2C19—blood—malaria	0.000751	0.00755	CbGeAlD
Lapatinib—Anaphylactic shock—Sulfadiazine—malaria	0.00075	0.00507	CcSEcCtD
Lapatinib—CYP3A5—kidney—malaria	0.000732	0.00735	CbGeAlD
Lapatinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000732	0.00494	CcSEcCtD
Lapatinib—Epistaxis—Pentoxifylline—malaria	0.00073	0.00493	CcSEcCtD
Lapatinib—Vomiting—Proguanil—malaria	0.000718	0.00485	CcSEcCtD
Lapatinib—Cardiac disorder—Quinidine—malaria	0.000716	0.00483	CcSEcCtD
Lapatinib—Cardiac disorder—Quinine—malaria	0.000716	0.00483	CcSEcCtD
Lapatinib—Anorexia—Sulfadiazine—malaria	0.000715	0.00483	CcSEcCtD
Lapatinib—Rash—Proguanil—malaria	0.000712	0.00481	CcSEcCtD
Lapatinib—Dermatitis—Proguanil—malaria	0.000712	0.00481	CcSEcCtD
Lapatinib—Headache—Proguanil—malaria	0.000708	0.00478	CcSEcCtD
Lapatinib—Immune system disorder—Quinine—malaria	0.000697	0.0047	CcSEcCtD
Lapatinib—Immune system disorder—Quinidine—malaria	0.000697	0.0047	CcSEcCtD
Lapatinib—Mediastinal disorder—Quinidine—malaria	0.000695	0.00469	CcSEcCtD
Lapatinib—Mediastinal disorder—Quinine—malaria	0.000695	0.00469	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000683	0.00461	CcSEcCtD
Lapatinib—Insomnia—Sulfadiazine—malaria	0.000678	0.00458	CcSEcCtD
Lapatinib—Mental disorder—Quinine—malaria	0.000676	0.00456	CcSEcCtD
Lapatinib—Mental disorder—Quinidine—malaria	0.000676	0.00456	CcSEcCtD
Lapatinib—Malnutrition—Quinine—malaria	0.000671	0.00453	CcSEcCtD
Lapatinib—Malnutrition—Quinidine—malaria	0.000671	0.00453	CcSEcCtD
Lapatinib—Nausea—Proguanil—malaria	0.000671	0.00453	CcSEcCtD
Lapatinib—CYP3A4—hematopoietic system—malaria	0.00067	0.00673	CbGeAlD
Lapatinib—Back pain—Clindamycin—malaria	0.000662	0.00447	CcSEcCtD
Lapatinib—CYP2C8—blood—malaria	0.000656	0.00659	CbGeAlD
Lapatinib—Decreased appetite—Sulfadiazine—malaria	0.000652	0.0044	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000648	0.00437	CcSEcCtD
Lapatinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000646	0.00436	CcSEcCtD
Lapatinib—Anaemia—Clindamycin—malaria	0.000632	0.00427	CcSEcCtD
Lapatinib—Immune system disorder—Quinidine barbiturate—malaria	0.000629	0.00425	CcSEcCtD
Lapatinib—Immune system disorder—Pentoxifylline—malaria	0.000628	0.00424	CcSEcCtD
Lapatinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000627	0.00424	CcSEcCtD
Lapatinib—CYP3A5—digestive system—malaria	0.000621	0.00624	CbGeAlD
Lapatinib—Cough—Dapsone—malaria	0.000617	0.00417	CcSEcCtD
Lapatinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000613	0.00414	CcSEcCtD
Lapatinib—Leukopenia—Clindamycin—malaria	0.000613	0.00414	CcSEcCtD
Lapatinib—Mental disorder—Quinidine barbiturate—malaria	0.00061	0.00412	CcSEcCtD
Lapatinib—Malnutrition—Quinidine barbiturate—malaria	0.000606	0.00409	CcSEcCtD
Lapatinib—Leukopenia—Quinine—malaria	0.000601	0.00406	CcSEcCtD
Lapatinib—Leukopenia—Quinidine—malaria	0.000601	0.00406	CcSEcCtD
Lapatinib—Palpitations—Quinine—malaria	0.000593	0.00401	CcSEcCtD
Lapatinib—Palpitations—Quinidine—malaria	0.000593	0.00401	CcSEcCtD
Lapatinib—Abdominal pain—Sulfadiazine—malaria	0.000593	0.004	CcSEcCtD
Lapatinib—CYP3A5—blood—malaria	0.000592	0.00594	CbGeAlD
Lapatinib—CYP2C19—liver—malaria	0.000588	0.0059	CbGeAlD
Lapatinib—Back pain—Pentoxifylline—malaria	0.000585	0.00395	CcSEcCtD
Lapatinib—Myalgia—Quinine—malaria	0.000572	0.00386	CcSEcCtD
Lapatinib—Myalgia—Quinidine—malaria	0.000572	0.00386	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000568	0.00383	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000568	0.00383	CcSEcCtD
Lapatinib—Anaemia—Pentoxifylline—malaria	0.000559	0.00378	CcSEcCtD
Lapatinib—Anaphylactic shock—Clindamycin—malaria	0.000559	0.00377	CcSEcCtD
Lapatinib—Hypersensitivity—Sulfadiazine—malaria	0.000553	0.00373	CcSEcCtD
Lapatinib—CYP3A4—kidney—malaria	0.00055	0.00552	CbGeAlD
Lapatinib—Leukopenia—Quinidine barbiturate—malaria	0.000542	0.00366	CcSEcCtD
Lapatinib—Leukopenia—Pentoxifylline—malaria	0.000541	0.00366	CcSEcCtD
Lapatinib—Nervous system disorder—Quinine—malaria	0.000537	0.00363	CcSEcCtD
Lapatinib—Nervous system disorder—Quinidine—malaria	0.000537	0.00363	CcSEcCtD
Lapatinib—Palpitations—Quinidine barbiturate—malaria	0.000535	0.00362	CcSEcCtD
Lapatinib—Palpitations—Pentoxifylline—malaria	0.000534	0.00361	CcSEcCtD
Lapatinib—Skin disorder—Quinine—malaria	0.000532	0.00359	CcSEcCtD
Lapatinib—Skin disorder—Quinidine—malaria	0.000532	0.00359	CcSEcCtD
Lapatinib—Pruritus—Sulfadiazine—malaria	0.000531	0.00358	CcSEcCtD
Lapatinib—Anorexia—Quinidine—malaria	0.000522	0.00353	CcSEcCtD
Lapatinib—Anorexia—Quinine—malaria	0.000522	0.00353	CcSEcCtD
Lapatinib—Insomnia—Dapsone—malaria	0.000522	0.00353	CcSEcCtD
Lapatinib—Myalgia—Quinidine barbiturate—malaria	0.000516	0.00348	CcSEcCtD
Lapatinib—Arthralgia—Quinidine barbiturate—malaria	0.000516	0.00348	CcSEcCtD
Lapatinib—Myalgia—Pentoxifylline—malaria	0.000515	0.00348	CcSEcCtD
Lapatinib—Diarrhoea—Sulfadiazine—malaria	0.000513	0.00347	CcSEcCtD
Lapatinib—CYP2C8—liver—malaria	0.000513	0.00515	CbGeAlD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000512	0.00346	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000511	0.00345	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Quinine—malaria	0.000499	0.00337	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Quinidine—malaria	0.000499	0.00337	CcSEcCtD
Lapatinib—Dyspnoea—Clindamycin—malaria	0.000498	0.00336	CcSEcCtD
Lapatinib—Anaphylactic shock—Pentoxifylline—malaria	0.000494	0.00333	CcSEcCtD
Lapatinib—Dyspepsia—Clindamycin—malaria	0.000492	0.00332	CcSEcCtD
Lapatinib—Infection—Pentoxifylline—malaria	0.00049	0.00331	CcSEcCtD
Lapatinib—Dyspnoea—Quinine—malaria	0.000488	0.0033	CcSEcCtD
Lapatinib—Dyspnoea—Quinidine—malaria	0.000488	0.0033	CcSEcCtD
Lapatinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000485	0.00327	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Clindamycin—malaria	0.000482	0.00326	CcSEcCtD
Lapatinib—Fatigue—Clindamycin—malaria	0.000482	0.00325	CcSEcCtD
Lapatinib—Skin disorder—Quinidine barbiturate—malaria	0.00048	0.00324	CcSEcCtD
Lapatinib—Skin disorder—Pentoxifylline—malaria	0.000479	0.00324	CcSEcCtD
Lapatinib—Constipation—Clindamycin—malaria	0.000478	0.00323	CcSEcCtD
Lapatinib—Vomiting—Sulfadiazine—malaria	0.000477	0.00322	CcSEcCtD
Lapatinib—Decreased appetite—Quinine—malaria	0.000476	0.00322	CcSEcCtD
Lapatinib—Decreased appetite—Quinidine—malaria	0.000476	0.00322	CcSEcCtD
Lapatinib—ABCB1—hematopoietic system—malaria	0.000475	0.00477	CbGeAlD
Lapatinib—Gastrointestinal disorder—Quinine—malaria	0.000473	0.00319	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Quinidine—malaria	0.000473	0.00319	CcSEcCtD
Lapatinib—Rash—Sulfadiazine—malaria	0.000473	0.00319	CcSEcCtD
Lapatinib—Dermatitis—Sulfadiazine—malaria	0.000472	0.00319	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dapsone—malaria	0.000472	0.00319	CcSEcCtD
Lapatinib—Anorexia—Quinidine barbiturate—malaria	0.000471	0.00318	CcSEcCtD
Lapatinib—Anorexia—Pentoxifylline—malaria	0.00047	0.00318	CcSEcCtD
Lapatinib—Headache—Sulfadiazine—malaria	0.00047	0.00317	CcSEcCtD
Lapatinib—CYP3A4—digestive system—malaria	0.000466	0.00468	CbGeAlD
Lapatinib—CYP3A5—liver—malaria	0.000463	0.00465	CbGeAlD
Lapatinib—Gastrointestinal pain—Clindamycin—malaria	0.000457	0.00308	CcSEcCtD
Lapatinib—Abdominal pain—Dapsone—malaria	0.000456	0.00308	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000451	0.00304	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00045	0.00304	CcSEcCtD
Lapatinib—Gastrointestinal pain—Quinine—malaria	0.000448	0.00303	CcSEcCtD
Lapatinib—Gastrointestinal pain—Quinidine—malaria	0.000448	0.00303	CcSEcCtD
Lapatinib—Insomnia—Pentoxifylline—malaria	0.000446	0.00301	CcSEcCtD
Lapatinib—Nausea—Sulfadiazine—malaria	0.000445	0.00301	CcSEcCtD
Lapatinib—CYP3A4—blood—malaria	0.000444	0.00446	CbGeAlD
Lapatinib—Abdominal pain—Clindamycin—malaria	0.000442	0.00298	CcSEcCtD
Lapatinib—Dyspnoea—Quinidine barbiturate—malaria	0.000441	0.00298	CcSEcCtD
Lapatinib—Dyspnoea—Pentoxifylline—malaria	0.00044	0.00297	CcSEcCtD
Lapatinib—Dyspepsia—Pentoxifylline—malaria	0.000434	0.00293	CcSEcCtD
Lapatinib—Abdominal pain—Quinidine—malaria	0.000433	0.00293	CcSEcCtD
Lapatinib—Abdominal pain—Quinine—malaria	0.000433	0.00293	CcSEcCtD
Lapatinib—Decreased appetite—Quinidine barbiturate—malaria	0.00043	0.0029	CcSEcCtD
Lapatinib—Decreased appetite—Pentoxifylline—malaria	0.000429	0.0029	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000427	0.00288	CcSEcCtD
Lapatinib—Constipation—Quinidine barbiturate—malaria	0.000423	0.00286	CcSEcCtD
Lapatinib—Constipation—Pentoxifylline—malaria	0.000422	0.00285	CcSEcCtD
Lapatinib—Hypersensitivity—Clindamycin—malaria	0.000411	0.00278	CcSEcCtD
Lapatinib—CYP2C8—brain—malaria	0.000407	0.00409	CbGeAlD
Lapatinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000404	0.00273	CcSEcCtD
Lapatinib—Hypersensitivity—Quinidine—malaria	0.000404	0.00273	CcSEcCtD
Lapatinib—Hypersensitivity—Quinine—malaria	0.000404	0.00273	CcSEcCtD
Lapatinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000404	0.00273	CcSEcCtD
Lapatinib—Asthenia—Clindamycin—malaria	0.000401	0.00271	CcSEcCtD
Lapatinib—Pruritus—Clindamycin—malaria	0.000395	0.00267	CcSEcCtD
Lapatinib—Asthenia—Quinine—malaria	0.000393	0.00265	CcSEcCtD
Lapatinib—Asthenia—Quinidine—malaria	0.000393	0.00265	CcSEcCtD
Lapatinib—Abdominal pain—Quinidine barbiturate—malaria	0.000391	0.00264	CcSEcCtD
Lapatinib—Abdominal pain—Pentoxifylline—malaria	0.00039	0.00264	CcSEcCtD
Lapatinib—ABCB1—kidney—malaria	0.000389	0.00391	CbGeAlD
Lapatinib—Pruritus—Quinine—malaria	0.000388	0.00262	CcSEcCtD
Lapatinib—Pruritus—Quinidine—malaria	0.000388	0.00262	CcSEcCtD
Lapatinib—Diarrhoea—Clindamycin—malaria	0.000382	0.00258	CcSEcCtD
Lapatinib—Diarrhoea—Quinidine—malaria	0.000375	0.00253	CcSEcCtD
Lapatinib—Diarrhoea—Quinine—malaria	0.000375	0.00253	CcSEcCtD
Lapatinib—Vomiting—Dapsone—malaria	0.000367	0.00248	CcSEcCtD
Lapatinib—Hypersensitivity—Quinidine barbiturate—malaria	0.000364	0.00246	CcSEcCtD
Lapatinib—Hypersensitivity—Pentoxifylline—malaria	0.000364	0.00246	CcSEcCtD
Lapatinib—Headache—Dapsone—malaria	0.000362	0.00244	CcSEcCtD
Lapatinib—Vomiting—Clindamycin—malaria	0.000355	0.0024	CcSEcCtD
Lapatinib—Asthenia—Quinidine barbiturate—malaria	0.000355	0.0024	CcSEcCtD
Lapatinib—Asthenia—Pentoxifylline—malaria	0.000354	0.00239	CcSEcCtD
Lapatinib—Rash—Clindamycin—malaria	0.000352	0.00238	CcSEcCtD
Lapatinib—Dermatitis—Clindamycin—malaria	0.000352	0.00238	CcSEcCtD
Lapatinib—Headache—Clindamycin—malaria	0.00035	0.00236	CcSEcCtD
Lapatinib—Pruritus—Quinidine barbiturate—malaria	0.00035	0.00236	CcSEcCtD
Lapatinib—Pruritus—Pentoxifylline—malaria	0.000349	0.00236	CcSEcCtD
Lapatinib—Vomiting—Quinidine—malaria	0.000348	0.00235	CcSEcCtD
Lapatinib—Vomiting—Quinine—malaria	0.000348	0.00235	CcSEcCtD
Lapatinib—CYP3A4—liver—malaria	0.000347	0.00349	CbGeAlD
Lapatinib—Rash—Quinidine—malaria	0.000345	0.00233	CcSEcCtD
Lapatinib—Rash—Quinine—malaria	0.000345	0.00233	CcSEcCtD
Lapatinib—Dermatitis—Quinine—malaria	0.000345	0.00233	CcSEcCtD
Lapatinib—Dermatitis—Quinidine—malaria	0.000345	0.00233	CcSEcCtD
Lapatinib—Headache—Quinidine—malaria	0.000343	0.00232	CcSEcCtD
Lapatinib—Headache—Quinine—malaria	0.000343	0.00232	CcSEcCtD
Lapatinib—Nausea—Dapsone—malaria	0.000343	0.00232	CcSEcCtD
Lapatinib—Diarrhoea—Quinidine barbiturate—malaria	0.000338	0.00228	CcSEcCtD
Lapatinib—Diarrhoea—Pentoxifylline—malaria	0.000338	0.00228	CcSEcCtD
Lapatinib—Nausea—Clindamycin—malaria	0.000332	0.00224	CcSEcCtD
Lapatinib—ABCB1—digestive system—malaria	0.00033	0.00331	CbGeAlD
Lapatinib—Nausea—Quinine—malaria	0.000325	0.0022	CcSEcCtD
Lapatinib—Nausea—Quinidine—malaria	0.000325	0.0022	CcSEcCtD
Lapatinib—ABCB1—blood—malaria	0.000314	0.00316	CbGeAlD
Lapatinib—Vomiting—Quinidine barbiturate—malaria	0.000314	0.00212	CcSEcCtD
Lapatinib—Vomiting—Pentoxifylline—malaria	0.000314	0.00212	CcSEcCtD
Lapatinib—Rash—Quinidine barbiturate—malaria	0.000312	0.00211	CcSEcCtD
Lapatinib—Dermatitis—Quinidine barbiturate—malaria	0.000311	0.0021	CcSEcCtD
Lapatinib—Rash—Pentoxifylline—malaria	0.000311	0.0021	CcSEcCtD
Lapatinib—Dermatitis—Pentoxifylline—malaria	0.000311	0.0021	CcSEcCtD
Lapatinib—Headache—Quinidine barbiturate—malaria	0.00031	0.00209	CcSEcCtD
Lapatinib—Headache—Pentoxifylline—malaria	0.000309	0.00209	CcSEcCtD
Lapatinib—ABCB1—bone marrow—malaria	0.000304	0.00306	CbGeAlD
Lapatinib—Nausea—Quinidine barbiturate—malaria	0.000294	0.00198	CcSEcCtD
Lapatinib—Nausea—Pentoxifylline—malaria	0.000293	0.00198	CcSEcCtD
Lapatinib—ABCB1—liver—malaria	0.000246	0.00247	CbGeAlD
Lapatinib—ABCB1—brain—malaria	0.000195	0.00196	CbGeAlD
Lapatinib—ERBB2—Signaling by SCF-KIT—IL6—malaria	9.62e-05	0.00143	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—KDR—malaria	9.62e-05	0.00143	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ACKR1—malaria	9.6e-05	0.00143	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD40LG—malaria	9.6e-05	0.00143	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FCGR2A—malaria	9.57e-05	0.00143	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HLA-B—malaria	9.51e-05	0.00142	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD8A—malaria	9.49e-05	0.00142	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—IL6—malaria	9.48e-05	0.00141	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—IL6—malaria	9.47e-05	0.00141	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD36—malaria	9.46e-05	0.00141	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ACKR1—malaria	9.45e-05	0.00141	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FCGR2A—malaria	9.42e-05	0.00141	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.35e-05	0.00139	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD36—malaria	9.32e-05	0.00139	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-B—malaria	9.27e-05	0.00138	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—KDR—malaria	9.26e-05	0.00138	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IFNG—malaria	9.25e-05	0.00138	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—IL6—malaria	9.21e-05	0.00137	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL1B—malaria	9.16e-05	0.00137	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-B—malaria	9.13e-05	0.00136	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL2—malaria	9.12e-05	0.00136	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD36—malaria	9.09e-05	0.00136	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—IL6—malaria	9.07e-05	0.00135	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—IL6—malaria	9.06e-05	0.00135	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD36—malaria	8.95e-05	0.00133	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD4—malaria	8.93e-05	0.00133	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—IL6—malaria	8.92e-05	0.00133	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CISH—malaria	8.69e-05	0.0013	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—IL6—malaria	8.65e-05	0.00129	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—IL6—malaria	8.61e-05	0.00128	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—IL6—malaria	8.57e-05	0.00128	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CRP—malaria	8.53e-05	0.00127	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—IL6—malaria	8.53e-05	0.00127	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—IL6—malaria	8.52e-05	0.00127	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	8.49e-05	0.00127	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—IL6—malaria	8.48e-05	0.00126	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—IL6—malaria	8.44e-05	0.00126	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CRP—malaria	8.4e-05	0.00125	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—IL6—malaria	8.4e-05	0.00125	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL1B—malaria	8.25e-05	0.00123	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL2—malaria	8.22e-05	0.00123	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FCGR2B—malaria	8.21e-05	0.00122	CbGpPWpGaD
Lapatinib—ERBB2—Disease—DHFR—malaria	8.19e-05	0.00122	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—TLR4—malaria	8.18e-05	0.00122	CbGpPWpGaD
Lapatinib—ERBB4—Disease—DHFR—malaria	8.07e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—TLR4—malaria	8.06e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—IL6—malaria	8.02e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	8.02e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—IL6—malaria	8.02e-05	0.0012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—IL6—malaria	7.95e-05	0.00119	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FCGR2A—malaria	7.94e-05	0.00118	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—IL6—malaria	7.9e-05	0.00118	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—IL6—malaria	7.9e-05	0.00118	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—IL6—malaria	7.9e-05	0.00118	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—IL6—malaria	7.88e-05	0.00117	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ACKR1—malaria	7.85e-05	0.00117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—IL6—malaria	7.84e-05	0.00117	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—IL6—malaria	7.83e-05	0.00117	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—IL6—malaria	7.76e-05	0.00116	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TLR9—malaria	7.74e-05	0.00115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—IL6—malaria	7.73e-05	0.00115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TLR9—malaria	7.62e-05	0.00114	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	7.58e-05	0.00113	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—ICAM1—malaria	7.53e-05	0.00112	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	7.48e-05	0.00112	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ICAM1—malaria	7.42e-05	0.00111	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TIRAP—malaria	7.32e-05	0.00109	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IFNG—malaria	7.14e-05	0.00107	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	7.1e-05	0.00106	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—IL6—malaria	7e-05	0.00104	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—IL1B—malaria	6.9e-05	0.00103	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CR1—malaria	6.8e-05	0.00101	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—malaria	6.65e-05	0.000991	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—HPGDS—malaria	6.5e-05	0.00097	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL1B—malaria	6.37e-05	0.00095	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL2—malaria	6.35e-05	0.000947	CbGpPWpGaD
Lapatinib—EGFR—Disease—PKLR—malaria	6.28e-05	0.000937	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KDR—malaria	6.27e-05	0.000936	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL18—malaria	5.93e-05	0.000885	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD40LG—malaria	5.91e-05	0.000881	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD8A—malaria	5.84e-05	0.000871	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL18—malaria	5.84e-05	0.000871	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD40LG—malaria	5.82e-05	0.000868	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR9—malaria	5.78e-05	0.000863	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—malaria	5.76e-05	0.000859	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD8A—malaria	5.76e-05	0.000858	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—malaria	5.68e-05	0.000846	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-B—malaria	5.62e-05	0.000838	CbGpPWpGaD
Lapatinib—EGFR—Disease—G6PD—malaria	5.6e-05	0.000835	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-B—malaria	5.54e-05	0.000826	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—malaria	5.53e-05	0.000825	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD36—malaria	5.51e-05	0.000822	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—IL6—malaria	5.46e-05	0.000815	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DHODH—malaria	5.46e-05	0.000814	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—malaria	5.45e-05	0.000813	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD36—malaria	5.43e-05	0.00081	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—IL6—malaria	5.38e-05	0.000803	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	5.37e-05	0.000802	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL6—malaria	5.36e-05	0.0008	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CD36—malaria	5.18e-05	0.000773	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—malaria	5.01e-05	0.000747	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CRP—malaria	4.97e-05	0.000741	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—IL6—malaria	4.94e-05	0.000737	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CRP—malaria	4.89e-05	0.00073	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—malaria	4.83e-05	0.00072	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TLR4—malaria	4.76e-05	0.00071	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DHODH—malaria	4.73e-05	0.000705	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD40LG—malaria	4.71e-05	0.000702	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TLR4—malaria	4.69e-05	0.0007	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HLA-B—malaria	4.67e-05	0.000696	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—malaria	4.66e-05	0.000695	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.65e-05	0.000694	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—malaria	4.65e-05	0.000694	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC4A1—malaria	4.64e-05	0.000692	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ACKR1—malaria	4.64e-05	0.000692	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FCGR2A—malaria	4.62e-05	0.00069	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—malaria	4.62e-05	0.00069	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD36—malaria	4.57e-05	0.000682	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ICAM1—malaria	4.57e-05	0.000681	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—malaria	4.52e-05	0.000674	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ICAM1—malaria	4.5e-05	0.000671	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-B—malaria	4.48e-05	0.000668	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KDR—malaria	4.48e-05	0.000668	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—malaria	4.45e-05	0.000664	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD36—malaria	4.39e-05	0.000655	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—malaria	4.38e-05	0.000653	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—malaria	4.37e-05	0.000652	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DECR1—malaria	4.37e-05	0.000651	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.27e-05	0.000637	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DHODH—malaria	4.22e-05	0.00063	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS2—malaria	4.18e-05	0.000624	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—malaria	4.18e-05	0.000624	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—malaria	4.16e-05	0.000621	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.15e-05	0.000619	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—malaria	4.14e-05	0.000618	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—malaria	4.12e-05	0.000615	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—malaria	4.12e-05	0.000615	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS2—malaria	4.12e-05	0.000615	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DHODH—malaria	4.12e-05	0.000614	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC4A1—malaria	4.02e-05	0.0006	CbGpPWpGaD
Lapatinib—EGFR—Disease—DHFR—malaria	3.96e-05	0.000591	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR4—malaria	3.95e-05	0.00059	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HBB—malaria	3.95e-05	0.000589	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—malaria	3.88e-05	0.000578	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—malaria	3.88e-05	0.000578	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	3.88e-05	0.000578	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—malaria	3.84e-05	0.000573	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.81e-05	0.000569	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—malaria	3.81e-05	0.000568	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—malaria	3.79e-05	0.000566	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DECR1—malaria	3.78e-05	0.000564	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TLR9—malaria	3.74e-05	0.000558	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ICAM1—malaria	3.64e-05	0.000543	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC4A1—malaria	3.59e-05	0.000535	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—malaria	3.53e-05	0.000526	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PKLR—malaria	3.52e-05	0.000525	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC4A1—malaria	3.5e-05	0.000522	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—malaria	3.48e-05	0.000518	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	3.43e-05	0.000512	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—malaria	3.42e-05	0.00051	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HBB—malaria	3.42e-05	0.00051	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DECR1—malaria	3.37e-05	0.000503	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—malaria	3.36e-05	0.000501	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	3.32e-05	0.000495	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—malaria	3.31e-05	0.000493	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DECR1—malaria	3.29e-05	0.000491	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—G6PD—malaria	3.14e-05	0.000468	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—malaria	3.12e-05	0.000465	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—malaria	3.1e-05	0.000462	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—malaria	3.1e-05	0.000462	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—malaria	3.09e-05	0.000461	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KDR—malaria	3.08e-05	0.000459	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—malaria	3.07e-05	0.000458	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—malaria	3.05e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—malaria	3.05e-05	0.000455	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HBB—malaria	3.05e-05	0.000455	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PKLR—malaria	3.05e-05	0.000455	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—malaria	3.04e-05	0.000454	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KDR—malaria	3.03e-05	0.000452	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HBB—malaria	2.98e-05	0.000444	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL18—malaria	2.87e-05	0.000428	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—malaria	2.86e-05	0.000426	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—malaria	2.83e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—malaria	2.79e-05	0.000415	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PKLR—malaria	2.72e-05	0.000406	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-B—malaria	2.72e-05	0.000405	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—G6PD—malaria	2.72e-05	0.000405	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	2.68e-05	0.0004	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—malaria	2.68e-05	0.000399	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD36—malaria	2.66e-05	0.000397	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PKLR—malaria	2.66e-05	0.000396	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—malaria	2.64e-05	0.000394	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DHODH—malaria	2.54e-05	0.000379	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—G6PD—malaria	2.42e-05	0.000362	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—malaria	2.4e-05	0.000358	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	2.39e-05	0.000357	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HPGDS—malaria	2.39e-05	0.000357	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—malaria	2.39e-05	0.000357	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—G6PD—malaria	2.37e-05	0.000353	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—malaria	2.3e-05	0.000343	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.28e-05	0.00034	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DHFR—malaria	2.22e-05	0.000331	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ICAM1—malaria	2.21e-05	0.000329	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SCARB1—malaria	2.2e-05	0.000327	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC4A1—malaria	2.16e-05	0.000322	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—malaria	2.11e-05	0.000315	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HPGDS—malaria	2.07e-05	0.000309	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DECR1—malaria	2.03e-05	0.000303	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—malaria	2.02e-05	0.000302	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—malaria	2e-05	0.000298	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—malaria	1.97e-05	0.000293	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DHFR—malaria	1.92e-05	0.000287	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SCARB1—malaria	1.9e-05	0.000284	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HPGDS—malaria	1.85e-05	0.000276	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBB—malaria	1.84e-05	0.000274	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—malaria	1.82e-05	0.000271	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HPGDS—malaria	1.8e-05	0.000269	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—malaria	1.79e-05	0.000267	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DHFR—malaria	1.72e-05	0.000256	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—malaria	1.71e-05	0.000254	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SCARB1—malaria	1.7e-05	0.000253	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—malaria	1.68e-05	0.000251	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—malaria	1.68e-05	0.00025	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DHFR—malaria	1.67e-05	0.00025	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SCARB1—malaria	1.66e-05	0.000247	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—malaria	1.65e-05	0.000246	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PKLR—malaria	1.64e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—malaria	1.63e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—malaria	1.62e-05	0.000242	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—malaria	1.51e-05	0.000225	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—malaria	1.5e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—malaria	1.5e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—malaria	1.49e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KDR—malaria	1.49e-05	0.000222	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—G6PD—malaria	1.46e-05	0.000217	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CD36—malaria	1.38e-05	0.000206	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CD36—malaria	1.19e-05	0.000178	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—malaria	1.17e-05	0.000175	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—malaria	1.16e-05	0.000172	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HPGDS—malaria	1.11e-05	0.000166	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CD36—malaria	1.07e-05	0.000159	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CD36—malaria	1.04e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DHFR—malaria	1.03e-05	0.000154	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SCARB1—malaria	1.02e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—malaria	9.65e-06	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—malaria	9.6e-06	0.000143	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—malaria	8.77e-06	0.000131	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—malaria	8.1e-06	0.000121	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CD36—malaria	6.41e-06	9.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—malaria	5.67e-06	8.46e-05	CbGpPWpGaD
